Skip to main content
Clinical Trials/NCT02211196
NCT02211196
Completed
Not Applicable

Implementing Evidence-Based Tobacco Cessation Strategies in Oncology Clinics

Wake Forest University Health Sciences1 site in 1 country377 target enrollmentFebruary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Malignant Neoplasm
Sponsor
Wake Forest University Health Sciences
Enrollment
377
Locations
1
Primary Endpoint
Percentage reporting they would be willing to participate in training on evidence-based tobacco cessation strategies
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This pilot clinical trial studies evidence-based tobacco cessation strategies in patients with cancer. Stop-smoking plans suggested by doctors may help patients with cancer quit smoking.

Detailed Description

PRIMARY OBJECTIVES: I. To assess oncology providers' self-reported need for training on evidence-based tobacco cessation strategies and assess their level of interest in future training on evidence-based tobacco cessation strategies. II. To test the feasibility of the implementation of evidence-based tobacco cessation strategies in community oncology clinics. III. To test the feasibility of surveying community oncology patients after a clinic visit to assess provider behavior regarding screening and brief intervention for tobacco use. OUTLINE: Patients complete a survey over approximately 10-15 minutes related to their provider's cessation advice and assistance with quitting. After completion of study, patients are followed up at 1 month.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
November 2014
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients with cancer who saw a provider will be eligible

Exclusion Criteria

  • Having a nurse or lab visit only

Outcomes

Primary Outcomes

Percentage reporting they would be willing to participate in training on evidence-based tobacco cessation strategies

Time Frame: Up to 1 month

Will be estimated and 95% CI constructed.

Proportion of patients who report that their provider asked about tobacco use during their visit

Time Frame: Up to 1 month

These prevalences will be estimated at pre- and post-intervention, and 95% CIs calculated adjusting for the expected within-clinic correlation of patient outcomes. These outcomes will be analyzed further using a subject-specific modeling approach to account for the correlation that occurs due to patients being clustered within clinics.

Proportion of current smokers who report that their provider advised them to quit during their visit and provided tobacco-cessation strategies

Time Frame: Up to 1 month

These prevalences will be estimated at pre- and post-intervention, and 95% CIs calculated adjusting for the expected within-clinic correlation of patient outcomes. These outcomes will be analyzed further using a subject-specific modeling approach to account for the correlation that occurs due to patients being clustered within clinics.

Percentage of providers from the Piedmont Oncology Association (POA) reporting a need for training on evidence-based tobacco cessation strategies

Time Frame: Up to 1 month

Will be estimated and 95% confidence intervals (CI) constructed.

Percentage reporting feeling very confident in their ability to counsel smokers

Time Frame: Up to 1 month

Will be estimated and 95% CI constructed.

Proportion of oncology patients willing to complete a survey in an oncology clinic

Time Frame: Up to 1 month

Will be estimated and 95% CI constructed.

Study Sites (1)

Loading locations...

Similar Trials